Works by Hong, David S

Results: 124
    1
    2

    Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study.

    Published in:
    2025
    By:
    • Thein, Kyaw Z.;
    • Karp, Daniel D.;
    • Tsimberidou, Apostolia;
    • Gong, Jing;
    • Sulovic, Selma;
    • Shah, Jatin;
    • Milton, Denái R.;
    • Hong, David S.;
    • Janku, Filip;
    • McQuinn, Lacey;
    • Stephen, Bettzy A.;
    • Colen, Rivka;
    • Carter, Brett W.;
    • Yap, Timothy A.;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Meric-Bernstam, Funda;
    • Naing, Aung
    Publication type:
    Correction Notice
    3

    Research Priorities of Individuals and Families With Sex Chromosome Aneuploidies.

    Published in:
    American Journal of Medical Genetics. Part A, 2025, v. 197, n. 6, p. 1, doi. 10.1002/ajmg.a.63998
    By:
    • Carl, Alexandra;
    • Bothwell, Samantha;
    • Farah, Fathia;
    • Swenson, Karli;
    • Hong, David;
    • Prakash, Siddharth;
    • Strang, John;
    • Tartaglia, Nicole;
    • Raznahan, Armin;
    • Ross, Judith;
    • Rogol, Alan D.;
    • Dawczyk, Anna;
    • Hong, David S.;
    • Decker, Gail;
    • Cover, Ginnie;
    • Cohen, Lilian L.;
    • Davis, Shanlee;
    • Gerken, Steve;
    • Howell, Susan;
    • Bamba, Vaneeta
    Publication type:
    Article
    4
    5

    Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00369-w
    By:
    • Alhalabi, Omar;
    • Groisberg, Roman;
    • Zinner, Ralph;
    • Hahn, Andrew W.;
    • Naing, Aung;
    • Zhang, Shizhen;
    • Tsimberidou, Apostolia M.;
    • Rodon, Jordi;
    • Fu, Siqing;
    • Yap, Timothy A.;
    • Hong, David S.;
    • Sun, Ming;
    • Jiang, Yunfang;
    • Pant, Shubham;
    • Shah, Amishi Y.;
    • Zurita, Amado;
    • Tannir, Nizar M.;
    • Vikram, Raghunandan;
    • Roszik, Jason;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    6

    BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-022-00341-0
    By:
    • Nelson, Blessie Elizabeth;
    • Roszik, Jason;
    • Janku, Filip;
    • Hong, David S.;
    • Kato, Shumei;
    • Naing, Aung;
    • Piha-Paul, Sarina;
    • Fu, Siqing;
    • Tsimberidou, Apostolia;
    • Cabanillas, Maria;
    • Busaidy, Naifa Lamki;
    • Javle, Milind;
    • Byers, Lauren Averett;
    • Heymach, John V.;
    • Meric-Bernstam, Funda;
    • Subbiah, Vivek
    Publication type:
    Article
    7

    Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
    By:
    • Vo, Henry Hiep;
    • Fu, Siqing;
    • Hong, David S.;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Naing, Aung;
    • Yap, Timothy A.;
    • Rodon, Jordi;
    • Ajani, Jaffer A.;
    • Cartwright, Carrie;
    • Johnson, Amber;
    • Song, I-Wen;
    • Beck, Jennifer;
    • Kahle, Michael;
    • Nogueras-Gonzalez, Graciela M.;
    • Miller, Vincent;
    • Chao, Calvin;
    • Vining, David J.
    Publication type:
    Article
    8

    A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
    By:
    • Mansfield, Aaron S.;
    • Hong, David S.;
    • Hann, Christine L.;
    • Farago, Anna F.;
    • Beltran, Himisha;
    • Waqar, Saiama N.;
    • Hendifar, Andrew E.;
    • Anthony, Lowell B.;
    • Taylor, Matthew H.;
    • Bryce, Alan H.;
    • Tagawa, Scott T.;
    • Lewis, Karl;
    • Niu, Jiaxin;
    • Chung, Christine H.;
    • Cleary, James M.;
    • Rossi, Michael;
    • Ludwig, Carrianne;
    • Valenzuela, Ricardo;
    • Luo, Yan;
    • Aggarwal, Rahul
    Publication type:
    Article
    9

    Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
    By:
    • Tsimberidou, Apostolia Maria;
    • Hong, David S.;
    • Fu, Siqing;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Kies, Merrill S.;
    • Ravi, Vinod;
    • Subbiah, Vivek;
    • Patel, Sunil M.;
    • Tu, Shi-Ming;
    • Janku, Filip;
    • Heymach, John;
    • Johnson, Amber;
    • Cartwright, Carrie;
    • Zhao, Li;
    • Zhang, Jianhua;
    • Berry, Donald A.;
    • Vining, David J.;
    • Futreal, Andrew;
    • Miller, Vincent A.
    Publication type:
    Article
    10

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    11
    12

    Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.

    Published in:
    Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00159-1
    By:
    • Subbiah, Vivek;
    • Dumbrava, Ecaterina Ileana;
    • Jiang, Yunfang;
    • Thein, Kyaw Z.;
    • Naing, Aung;
    • Hong, David S.;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Tsimberidou, Apostolia M.;
    • Janku, Filip;
    • Meric-Bernstam, Funda;
    • Kurzrock, Razelle;
    • Falchook, Gerald
    Publication type:
    Article
    13
    14
    15

    Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3246, doi. 10.3390/cancers12113246
    By:
    • Italiano, Antoine;
    • Nanda, Shivani;
    • Briggs, Andrew;
    • Garcia-Foncillas, Jesus;
    • Lassen, Ulrik;
    • Vassal, Gilles;
    • Kummar, Shivaani;
    • van Tilburg, Cornelis M.;
    • Hong, David S.;
    • Laetsch, Theodore W.;
    • Keating, Karen;
    • Reeves, John A.;
    • Fellous, Marc;
    • Childs, Barrett H.;
    • Drilon, Alexander;
    • Hyman, David M.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.70130
    By:
    • Butner, Joseph D.;
    • Martin, Geoffrey V.;
    • Zhihui Wang;
    • Corradetti, Bruna;
    • Ferrari, Mauro;
    • Esnaola, Nestor;
    • Chung, Caroline;
    • Hong, David S.;
    • Welsh, James W.;
    • Hasegawa, Naomi;
    • Mittendorf, Elizabeth A.;
    • Curley, Steven A.;
    • Shu-Hsia Chen;
    • Ping-Ying Pan;
    • Libutti, Steven K.;
    • Ganesan, Shridar;
    • Sidman, Richard L.;
    • Pasqualini, Renata;
    • Arap, Wadih;
    • Koay, Eugene J.
    Publication type:
    Article
    23

    Associations between the gut microbiome and fatigue in cancer patients.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84783-9
    By:
    • Hajjar, Joud;
    • Mendoza, Tito;
    • Zhang, Liangliang;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Janku, Filip;
    • Karp, Daniel D.;
    • Ballhausen, Alexej;
    • Gong, Jing;
    • Zarifa, Abdulrazzak;
    • Peterson, Christine B.;
    • Meric-Bernstam, Funda;
    • Jenq, Robert;
    • Naing, Aung
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Deep Learning–Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model.

    Published in:
    JAMA Network Open, 2019, v. 2, n. 6, p. e195600, doi. 10.1001/jamanetworkopen.2019.5600
    By:
    • Park, Allison;
    • Chute, Chris;
    • Rajpurkar, Pranav;
    • Lou, Joe;
    • Ball, Robyn L.;
    • Shpanskaya, Katie;
    • Jabarkheel, Rashad;
    • Kim, Lily H.;
    • McKenna, Emily;
    • Tseng, Joe;
    • Ni, Jason;
    • Wishah, Fidaa;
    • Wittber, Fred;
    • Hong, David S.;
    • Wilson, Thomas J.;
    • Halabi, Safwan;
    • Basu, Sanjay;
    • Patel, Bhavik N.;
    • Lungren, Matthew P.;
    • Ng, Andrew Y.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv098
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P.;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A.;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M.;
    • Broaddus, Russell;
    • Bernstam, Elmer V.;
    • Shaw, Kenna R.;
    • Mendelsohn, John;
    • Mills, Gordon B.
    Publication type:
    Article
    39

    A decision support framework for genomically informed investigational cancer therapy.

    Published in:
    2015
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A;
    • Piha-Paul, Sarina A;
    • Hong, David S;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M;
    • Broaddus, Russell;
    • Bernstam, Elmer V;
    • Shaw, Kenna R;
    • Mendelsohn, John;
    • Mills, Gordon B
    Publication type:
    journal article
    40

    Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 6, p. 997, doi. 10.1093/neuonc/noab274
    By:
    • Doz, François;
    • Tilburg, Cornelis M van;
    • Geoerger, Birgit;
    • Højgaard, Martin;
    • Øra, Ingrid;
    • Boni, Valentina;
    • Capra, Michael;
    • Chisholm, Julia;
    • Chung, Hyun Cheol;
    • DuBois, Steven G;
    • Gallego-Melcon, Soledad;
    • Gerber, Nicolas U;
    • Goto, Hiroaki;
    • Grilley-Olson, Juneko E;
    • Hansford, Jordan R;
    • Hong, David S;
    • Italiano, Antoine;
    • Kang, Hyoung Jin;
    • Nysom, Karsten;
    • Thorwarth, Anne
    Publication type:
    Article
    41
    42
    43
    44

    Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
    By:
    • Nelson, Blessie Elizabeth;
    • Saleem, Sadia;
    • Damodaran, Senthil;
    • Somaiah, Neeta;
    • Piha‐Paul, Sarina;
    • Moore, Julia Ann;
    • Yilmaz, Bulent;
    • Ogbonna, Deby;
    • Karp, Daniel D.;
    • Dumbrava, Ecaterina;
    • Tsimberidou, Apostolia M.;
    • Hong, David S.;
    • Rodon Ahnert, Jordi;
    • Milton, Denái R.;
    • Zheng, Xiaofeng;
    • Booser, Daniel J.;
    • Ibrahim, Nuhad K.;
    • Conley, Anthony P.;
    • Bhosale, Priya;
    • Rojas Hernandez, Cristhiam M.
    Publication type:
    Article
    45
    46
    47

    Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 14, p. 2164, doi. 10.1002/cncr.28701
    By:
    • Hong, David S.;
    • Garrido‐Laguna, Ignacio;
    • Ekmekcioglu, Suhendan;
    • Falchook, Gerald S.;
    • Naing, Aung;
    • Wheler, Jennifer J.;
    • Fu, Siqing;
    • Moulder, Stacy L.;
    • Piha‐Paul, Sarina;
    • Tsimberidou, Apostolia M.;
    • Wen, YueJin;
    • Culotta, Kirk S.;
    • Anderes, Kenna;
    • Davis, Darren W.;
    • Liu, Wen;
    • George, Goldy C.;
    • Camacho, Luis H.;
    • Percy Ivy, Susan;
    • Kurzrock, Razelle
    Publication type:
    Article
    48
    49
    50